Wikisage, the free encyclopedia of the second generation, is digital heritage
Zonisamide: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
zonisamide is | zonisamide is an 1,2-benzisoxazole-3-methanesulfonamide, that was initally used as anticonvulsant drug and latter as Parkinson-drug. | ||
1,2-benzisoxazole-3-methanesulfonamide, that was initally used as anticonvulsant drug and latter as Parkinson-drug | |||
| Line 10: | Line 9: | ||
[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451432/ Efficacy and Tolerability of Second and Third Generation Anti-epileptic Drugs in Refractory Epilepsy: A Network Meta-Analysis] | [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451432/ Efficacy and Tolerability of Second and Third Generation Anti-epileptic Drugs in Refractory Epilepsy: A Network Meta-Analysis] | ||
<references/> | |||
[[wikipedia:zonisamide]] | [[wikipedia:zonisamide]] | ||
Revision as of 23:49, 25 August 2017
zonisamide is an 1,2-benzisoxazole-3-methanesulfonamide, that was initally used as anticonvulsant drug and latter as Parkinson-drug.
It inhibitory action of carbonic anhydrase coulby related with perception of taste, and the novo lipogenesis
[1]
Zonisamide inhibits monoaminooxidaseand enhances motor perfomance and social activity